Most major global financial assets have reacted as largely expected to Donald Trump's victory in the U.S. presidential ...
Eric Jackson, the founder and portfolio manager at EMJ Capital, has shared his thoughts on the potential catalysts that could ...
Citron said it had hedged its perspective with a short position against MicroStrategy, even though it maintained a positive ...
Bitcoin (BTC-USD) is set to rise 8.3% on a weekly basis, as the cryptocurrency continues to see a meteoric rise after Donald ...
Jim Cramer says ‘all I can tell you is to own Bitcoin, that’s a winner’, flash crash imminent?
On November 22, renowned (and infamous) investor Jim Cramer revealed his bullish stance — now, some are worried that BTC ...
Famed investor dubs Bitcoin a winner as he picks it over MSTR. Citron recently revealed a short position in MicroStrategy ...
Cryptopolitan on MSN1d
MicroStrategy completes $3B offering of convertible Senior Notes due 2029MicroStrategy, a leading business intelligence firm, announced the completion of its 0% convertible senior notes offering worth $3B, which is due in 2029. The money raised will be used to purchase ...
Major equity averages closed higher Thursday, helped by Nvidia (NVDA) shares escaping negative territory, while market ...
MicroStrategy Incorporated (NASDAQ:MSTR) has experienced an extraordinary 674% increase in its stock price year-to-date in 2024, a rally driven by its massive Bitcoin holdings and the cryptocurrency’s ...
Citron Research’s Andrew Left believes the run in shares of MicroStrategy Inc (NASDAQ:MSTR) is not going to end well in the ...
Well, this is a Bitcoin surprise. Michael Saylor, the Executive Chairman of MicroStrategy, has lost his voting control over ...
Jazz Pharmaceuticals (NASDAQ:JAZZ) and Zymeworks (NASDAQ:ZYME) announced Thursday the FDA approval of their jointly developed bispecific antibody Ziihera as a late-line treatment for certain adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback